Osteoporosis Treatment Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Osteoporosis Treatment Market

1.1. Definition and Scope

1.1.1. Definition of Osteoporosis Treatment

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Osteoporosis Treatment Market

1.2. Summary

1.2.1. Executive Summary

1.2.2. Osteoporosis Treatment Market By Drug Class

1.2.3. Osteoporosis Treatment Market By Route of Administration

1.2.4. Osteoporosis Treatment Market By Distribution Channel

1.2.5. Osteoporosis Treatment Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Osteoporosis Treatment Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Osteoporosis Treatment Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of Major Manufacturers in 2021

CHAPTER 5. Osteoporosis Treatment Market By Drug Class

5.1. Introduction

5.2. Osteoporosis Treatment Market Revenue By Drug Class

5.2.1. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast, By Drug Class, 2018-2030

5.2.2. Bisphosphonate

5.2.2.1. Bisphosphonate Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.2. Alendronate

5.2.2.2.1. Alendronate Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.3. Risedronate

5.2.2.3.1. Risedronate Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.4. Ibandronate

5.2.2.4.1. Ibandronate Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.5. Zoledronic Acid

5.2.2.5.1. Zoledronic Acid Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.2.6. Others

5.2.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Calcitonin

5.2.3.1. Calcitonin Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Hormone Replacement Therapy

5.2.4.1. Hormone Replacement Therapy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Selective Estrogen Receptor Modulators (SERMs)

5.2.5.1. Selective Estrogen Receptor Modulators (SERMs) Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.6. Parathyroid Hormone-Related Protein (PTHrP) Analog

5.2.6.1. Parathyroid Hormone-Related Protein (PTHrP) Analog Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.7. Rank Ligand (RANKL) Inhibitor

5.2.7.1. Rank Ligand (RANKL) Inhibitor Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Osteoporosis Treatment Market By Route of Administration

6.1. Introduction

6.2. Osteoporosis Treatment Market Revenue By Route of Administration

6.2.1. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast, By Route of Administration, 2018-2030

6.2.2. Injectables

6.2.2.1. Injectables Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Oral

6.2.3.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Others

6.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. Osteoporosis Treatment Market By Distribution Channel

7.1. Introduction

7.2. Osteoporosis Treatment Market Revenue By Distribution Channel 

7.2.1. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030

7.2.2. Retail Pharmacies & Stores

7.2.2.1. Retail Pharmacies & Stores Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.3. Hospitals Pharmacies

7.2.3.1. Hospitals Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.4. Online Pharmacies

7.2.4.1. Online Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 8. North America Osteoporosis Treatment Market By Country

8.1. North America Osteoporosis Treatment Market Overview

8.2. U.S.

8.2.1. U.S. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

8.2.2. U.S. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

8.2.3. U.S. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.3. Canada

8.3.1. Canada Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

8.3.2. Canada Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

8.3.3. Canada Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.4. North America PEST Analysis

CHAPTER 9. Europe Osteoporosis Treatment Market By Country

9.1. Europe Osteoporosis Treatment Market Overview

9.2. U.K.

9.2.1. U.K. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

9.2.2. U.K. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.2.3. U.K. Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.3. Germany

9.3.1. Germany Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

9.3.2. Germany Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.3.3. Germany Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.4. France

9.4.1. France Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

9.4.2. France Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.4.3. France Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.5. Spain

9.5.1. Spain Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

9.5.2. Spain Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.5.3. Spain Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.6. Rest of Europe

9.6.1. Rest of Europe Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

9.6.2. Rest of Europe Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.6.3. Rest of Europe Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.7. Europe PEST Analysis

CHAPTER 10. Asia-Pacific Osteoporosis Treatment Market By Country

10.1. Asia-Pacific Osteoporosis Treatment Market Overview

10.2. China

10.2.1. China Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

10.2.2. China Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.2.3. China Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.3. Japan

10.3.1. Japan Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

10.3.2. Japan Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.3.3. Japan Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.4. India

10.4.1. India Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

10.4.2. India Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.4.3. India Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.5. India Australia

10.5.1. Australia Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

10.5.2. Australia Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.5.3. Australia Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.6. South Korea

10.6.1. South Korea Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

10.6.2. South Korea Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.6.3. South Korea Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

10.7.2. Rest of Asia-Pacific Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.7.3. Rest of Asia-Pacific Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.8. Asia-Pacific PEST Analysis

CHAPTER 11. Latin America Osteoporosis Treatment Market By Country

11.1. Latin America Osteoporosis Treatment Market Overview

11.2. Brazil

11.2.1. Brazil Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

11.2.2. Brazil Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.2.3. Brazil Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.3. Mexico

11.3.1. Mexico Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

11.3.2. Mexico Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.3.3. Mexico Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.4. Rest of Latin America

11.4.1. Rest of Latin America Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

11.4.2. Rest of Latin America Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.4.3. Rest of Latin America Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Osteoporosis Treatment Market By Country 

12.1. Middle East & Africa Osteoporosis Treatment Market Overview

12.2. GCC

12.2.1. GCC Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

12.2.2. GCC Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.2.3. GCC Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.3. South Africa

12.3.1. South Africa Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

12.3.2. South Africa Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.3.3. South Africa Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Drug Class, 2018-2030

12.4.2. Rest of Middle East & Africa Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

12.4.3. Rest of Middle East & Africa Osteoporosis Treatment Market Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Osteoporosis Treatment Market

13.1. Osteoporosis Treatment Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Osteoporosis Treatment Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Amgen Inc.

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2021

14.1.3.2. Amgen Inc. 2021 Osteoporosis Treatment Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Asahi Kasei Corporation

14.3. DAIICHI SANKYO COMPANY, LIMITED

14.4. Dr. Reddy’s Laboratories Ltd.

14.5. Eli Lilly and Company

14.6. F. Hoffmann-La Roche Ltd

14.7. GSK plc.

14.8. Ligand Pharmaceuticals Incorporated

14.9. Merck & Co., Inc.

14.10. Novartis AG

14.11. Pfizer Inc.

14.12. Teva Pharmaceutical Industries Ltd.

14.13. Viatris Inc.